These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29661431)

  • 1. Stratifying Mortality in a Model for End-Stage Liver Disease Waiting List: A Brazilian Single-Center Study.
    Martino RB; Waisberg DR; Dias APM; Inoue VBS; Arantes RM; Haddad LBP; Andraus W; Lopes LD; Galvão FHF; Song ATW; D'Albuquerque LAC
    Transplant Proc; 2018 Apr; 50(3):758-761. PubMed ID: 29661431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal vein thrombosis and survival in patients with cirrhosis.
    Englesbe MJ; Kubus J; Muhammad W; Sonnenday CJ; Welling T; Punch JD; Lynch RJ; Marrero JA; Pelletier SJ
    Liver Transpl; 2010 Jan; 16(1):83-90. PubMed ID: 20035521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
    Genda T; Ichida T; Sakisaka S; Sata M; Tanaka E; Inui A; Egawa H; Umeshita K; Furukawa H; Kawasaki S; Inomata Y
    J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M; Agarwal S; Lacerda M; Chalasani N; Kwo P; Tector AJ
    Transplantation; 2016 Jan; 100(1):126-33. PubMed ID: 26050013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
    Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
    J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy.
    Ferrarese A; Battistella S; Germani G; Russo FP; Senzolo M; Gambato M; Vitale A; Cillo U; Burra P
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208613
    [No Abstract]   [Full Text] [Related]  

  • 10. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
    Thuluvath PJ; Hanish S; Savva Y
    Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.
    Salvalaggio P; Afonso RC; Pereira LA; Ferraz-Neto BH
    Einstein (Sao Paulo); 2012; 10(3):278-85. PubMed ID: 23386004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of portal vein thrombosis in patients with autoimmune hepatitis on the liver transplantation waiting list.
    Ruiz P; Sastre L; Crespo G; Blasi A; Colmenero J; García-Valdecasas JC; Navasa M
    Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nontumoral portal vein thrombosis in patients awaiting liver transplantation.
    Chen H; Turon F; Hernández-Gea V; Fuster J; Garcia-Criado A; Barrufet M; Darnell A; Fondevila C; Garcia-Valdecasas JC; Garcia-Pagán JC
    Liver Transpl; 2016 Mar; 22(3):352-65. PubMed ID: 26684272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of Portal Vein Thrombosis Prior to Liver Transplantation: A Retrospective Cohort Study.
    Karvellas CJ; Cardoso FS; Senzolo M; Wells M; Alghanem MG; Handou F; Kwapisz L; Kneteman NM; Marotta PJ; Al-Judaibi B
    Ann Hepatol; 2017; 16(2):236-436. PubMed ID: 28233745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
    Cepeda-Franco C; Bernal-Bellido C; Barrera-Pulido L; Álamo-Martínez JM; Ruiz-Matas JH; Suárez-Artacho G; Marín-Gómez LM; Tinoco-González J; Díaz-Aunión C; Padillo-Ruiz FJ; Gómez-Bravo MÁ
    Transplant Proc; 2016 Nov; 48(9):2983-2986. PubMed ID: 27932125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.
    Freitas AC; Itikawa WM; Kurogi AS; Stadnik LG; Parolin MB; Coelho JC
    Arq Gastroenterol; 2010; 47(3):233-7. PubMed ID: 21140081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant.
    Montenovo M; Rahnemai-Azar A; Reyes J; Perkins J
    Exp Clin Transplant; 2018 Apr; 16(2):166-171. PubMed ID: 28621635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.